We are live on ! Find out more
IA

IFP Advisors Portfolio holdings

AUM $5.54B
1-Year Est. Return 27.43%
This Fund
S&P 500
This Quarter Est. Return
-1.75%
1 Year Est. Return
+27.43%
3 Year Est. Return
+73.16%
5 Year Est. Return
+63.71%
10 Year Est. Return
–
AUM
$2.21B
AUM Growth
$0
Cap. Flow
+$623K
Cap. Flow %
0.03%
Top 10 Hldgs %
16%
Holding
3,948
New
–
Increased
57
Reduced
11
Closed
51

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$3.44M
2
NYRT
New York REIT, Inc.
NYRT
+$914K
3
QCOM icon
Qualcomm
QCOM
+$631K
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$444K
5
FMI
Foundation Medicine, Inc.
FMI
+$266K

Top Sells

Rank Stock Value
1
BF.B icon
Brown-Forman Class B
BF.B
+$198K
2
AFL icon
Aflac
AFL
+$162K
3
BP icon
BP
BP
+$116K
4
HEI icon
HEICO Corp
HEI
+$72.7K
5
FISV
Fiserv Inc
FISV
+$19.8K

Sector Composition

Rank Sector Weight
1 Technology 6.27%
2 Financials 5.46%
3 Healthcare 5.13%
4 Consumer Discretionary 4.05%
5 Industrials 3.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RAS
3926
DELISTED
RAIT Financial Trust
RAS
$0 ﹤0.01%
333
– –
PGH
3927
DELISTED
Pengrowth Energy Corporation
PGH
$0 ﹤0.01%
266
– –
RIBT
3928
DELISTED
RiceBran Technologies
RIBT
– –
0
– –
ERUS
3929
DELISTED
iShares MSCI Russia ETF
ERUS
$0 ﹤0.01%
3
– –
BVSN
3930
DELISTED
Broadvision Inc Com
BVSN
$0 ﹤0.01%
4
– –
KEG
3931
DELISTED
Key Energy Services, Inc. Common Stock
KEG
$0 ﹤0.01%
1
– –
TI
3932
DELISTED
Telecom Italia
TI
$0 ﹤0.01%
10
– –
IMUC
3933
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
$0 ﹤0.01%
95
– –
CGG
3934
DELISTED
CGG
CGG
$0 ﹤0.01%
11
– –
ARLZ
3935
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$0 ﹤0.01%
300
– –
SGY
3936
DELISTED
Stone Energy
SGY
$0 ﹤0.01%
5
– –
OREX
3937
DELISTED
Orexigen Therapeutics, Inc.
OREX
$0 ﹤0.01%
100
– –
RTK
3938
DELISTED
Rentech, Inc.
RTK
$0 ﹤0.01%
30
– –
VXX
3939
CALL
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
– –
-400
Closed -$12K
FNSR
3940
CALL
DELISTED
Finisar Corp
FNSR
– –
-5,200
Closed -$106K
RPRX
3941
DELISTED
Repros Therapeutics Inc.
RPRX
$0 ﹤0.01%
12
– –
GCVRZ
3942
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$0 ﹤0.01%
900
– –
BHVN
3943
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$0 ﹤0.01%
12
– –
NEP
3944
DELISTED
CHINA NORTH EAST PETROLEUM HLDGS LTD
NEP
$0 ﹤0.01%
1,000
– –
154 155 156 157
158

Similar funds

AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
GVAG
Great Valley Advisor Group Wilmington, Delaware $5.5B AUM 20.56% 1-Year Est. Return
SWP
Sagespring Wealth Partners Franklin, Tennessee $5.49B AUM 19.47% 1-Year Est. Return

IFP Advisors's Q1 2018 Portfolio in Review

As of Q1 2018, IFP Advisors held 3,948 positions worth $2.21B, unchanged from the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q1 2018: portfolio turnover was 1.3%. IFP Advisors opened no new positions and exited 51, leaving the 3,948-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.

  • IFP Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2018, an estimated $3.44M increase.
  • IFP Advisors's biggest Q1 2018 reduction was Brown-Forman Class B, cutting an estimated $198K.
  • IFP Advisors's ten largest holdings make up 16% of its $2.21B portfolio in Q1 2018.
  • IFP Advisors opened 0 new positions and closed 51 in Q1 2018.
  • IFP Advisors's portfolio value was unchanged quarter-over-quarter at $2.21B.

Based on IFP Advisors's 13F filing for Q1 2018, filed 9 May 2018.